Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K192978
    Date Cleared
    2020-11-12

    (385 days)

    Product Code
    Regulation Number
    880.6860
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K192980, K930683, K191021, K151585

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The EOGas 4 Ethylene Oxide Gas Sterilize is designed to sterilize reusable medical devices that are sensitive to moisture, heat, chemical corrosion, or radiation. The critical process parameters for the two available cycles are summarized below:

    Table 1. EOGas 4 Ethylene Oxide Sterilizer cycle parameters

    EO Exposure TimeTotal Cycle TimeEO AmountTemperatureRelative Humidity
    3 hours3.5 hours17.6 g ± 5%50°C ± 3°C35-70%
    6 hours7 hours

    The differences between the two options are the length of EO gas exposure and the length of mandatory ventilation after gas exposure; the gas exposure is chosen based on the devices to be sterilized. The appropriate purge probe and process challenge device (PCD) must be used: EOGas 4 SteriTest for a 3-hour gas exposure, EOGas 4 Endo-SteriTest for a 6-hour gas exposure.

    The EOGas 4 Ethylene Oxide Gas Sterilizer 3-hour gas exposure is used for surface sterilization of medical devices, including instruments with diffusion-restricted spaces (hinges or mated surfaces), as well as for the sterilization of endoscopes with working length shorter than 1100 mm as specified in the labeling. The EOGas 4 SteriTest PCD is used with the 3-hour gas exposure.

    The EOGas 4 Ethylene Oxide Gas Sterilizer 6-hour gas exposure is used for sterilization of duodenoscopes and colonoscopes with working length longer than 1100 mm as specified in the labeling. The EOGas 4 Endo-SteriTest PCD is used with the 6-hour gas exposure.

    Device Description

    The EOGas 4 Ethylene Oxide Gas Sterilizer, model AN4000.60 (115V) or AN4000.61 (230V), is intended to sterilize moisture, temperature, chemical corrosion, or radiation-sensitive reusable medical devices in healthcare facilities. The sterilant is a unit dose of 100% ethylene oxide contained in a cartridge, and the sterilization chamber is a gas-impervious flexible sterilization bag.

    AI/ML Overview

    Here's a summary of the acceptance criteria and study information for the EOGas 4 Ethylene Oxide Gas Sterilizer, based on the provided document:

    Acceptance Criteria and Device Performance

    TestAcceptance CriteriaReported Device Performance
    Minimum Sterilization ParametersThe EO gas exposure time at 50°C in an EOGas 4 sterilizer must result in sterilization of the endoscope loads.Using a 6-hour EO gas exposure in the EOGas 4 sterilizer, 6-Log biological indicators were consistently inactivated for two duodenoscopes, two colonoscopes, or one colonoscope and one duodenoscope in each load. The minimum parameters for sterilization of two duodenoscopes or colonoscopes are 518 mg/L EO, 46.4°C, and 35% RH.
    Half Dose ValidationFor consecutive half dose cycles and full dose cycles:
    EO concentration is half when half the amount of EO is used.
    All 6-Log Bacillus atrophaeus biological indicators, inoculated at the worst-case locations of the tested endoscopes, are inactivated.Consecutive half dose cycles and full dose cycles were performed. The EO concentration was half when half the amount of EO was used. The cumulative lethality of half dose cycles was half the lethality of full dose cycle. The cycles consistently inactivated all 6-Log Bacillus atrophaeus biological indicators inoculated at the midpoint of the tested channels and at the elevator mechanism of duodenoscopes, as well as the water jet channel of the colonoscopes.
    Simulated-Use TestingFor consecutive full dose cycles:
    Biological indicators with 6-Log Bacillus atrophaeus, prepared in an artificial soil and inoculated at the worst-case locations of the tested endoscopes, are inactivated.Biological indicators with 6-Log Bacillus atrophaeus were prepared in an artificial soil and inoculated at the center of the tested channels and at the elevator mechanism of duodenoscopes as well as the water jet channel of the colonoscopes. Inactivated biological indicators were obtained in all cycles for all duodenoscope and colonoscope loads tested.
    In-Use TestingDuodenoscopes and colonoscopes, used on patients, cleaned but not disinfected, are sterilized using the 6-hour cycle at 50°C in an EOGas 4 sterilizer.Duodenoscopes and colonoscopes, used on patients, were cleaned per hospital protocol but not disinfected, processed using the 6-hour EO exposure at 50°C in the EOGas 4 sterilizer; sterility was tested by a flush method per USP. All test cultures from the processed duodenoscopes and colonoscopes were sterile.
    EO ResidualsAfter additional aeration following the cycle, EO residuals on duodenoscopes and colonoscopes are evaluated, and the residuals on the endoscopes and accessories meet the requirements of ANSI/AAMI/ISO 10993-7.Olympus TJF-Q180V, TJF-Q160VF, TJF-Q190V, PJF-160, CF-Q180AL, Pentax ED34-i10T2, ED-3490TK duodenoscopes and EC-3490Li colonoscopes wrapped in Sterisheet must aerate for an additional 6 hours after the cycle. Fujifilm ED-530XT and EC-600HL wrapped in Sterisheet must aerate for an additional 8 hours after the cycle. After 6 hours of additional aeration, EO residuals on the packaging materials met the requirements of ANSI/AAMI/ISO 10993-7.

    Study Information:

    1. Sample sizes used for the test set and data provenance:

      • Minimum Sterilization Parameters: Performed to define and validate the endoscope loads. The results indicate successful inactivation of 6-Log BIs for "two duodenoscopes, two colonoscopes, or one colonoscope and one duodenoscope in each load." The exact number of each type of load tested isn't specified, but implies multiple runs for different combinations.
      • Half Dose Validation: "Consecutive half dose cycles and full dose cycles were performed." No specific number of cycles or endoscopes is provided.
      • Simulated-Use Testing: "Inactivated biological indicators were obtained in all cycles for all duodenoscope and colonoscope loads tested." Again, the exact number of cycles or endoscopes is not specified.
      • In-Use Testing: "Duodenoscopes and colonoscopes, used on patients... processed using the 6-hour EO exposure." No specific number of patient-used scopes is provided.
      • EO Residuals: Tested on "Olympus TJF-Q180V, TJF-Q160VF, TJF-Q190V, PJF-160, CF-Q180AL, Pentax ED34-i10T2, ED-3490TK duodenoscopes and EC-3490Li colonoscopes" and "Fujifilm ED-530XT and EC-600HL." This indicates testing on a variety of endoscope models.
      • Data Provenance: The document does not explicitly state the country of origin or whether the data was retrospective or prospective. Given the context of a 510(k) submission for a medical device cleared in the U.S., the testing would typically be conducted to U.S. regulatory standards. "In-Use Testing" mentions "used in routine endoscopic procedures in a hospital or clinic setting," suggesting prospective collection of real-world use data.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • This document describes performance testing of a sterilizer, where the "ground truth" is defined by the inactivation of biological indicators and the adherence to specified chemical and physical parameters. These are objective measures and do not typically involve human "experts" establishing a subjective ground truth, as would be the case for image interpretation or diagnosis. Therefore, no information on experts for ground truth is applicable or provided.
    3. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

      • Not applicable. As noted above, the ground truth is based on objective laboratory measurements (biological indicator cultures, chemical concentrations, temperature, humidity, and residual levels), not a subjective human assessment requiring adjudication.
    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • Not applicable. This document pertains to the validation of an ethylene oxide gas sterilizer, not an AI-powered diagnostic or interpretive device. Therefore, no MRMC study or AI assistance evaluation was performed.
    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

      • Not applicable. This device is a sterilizer, not an algorithm. Its performance is evaluated through its physical and biological sterilization capabilities.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • The ground truth for the sterilization efficacy tests is primarily established by:
        • Biological Inactivation: The complete inactivation of 6-Log Bacillus atrophaeus biological indicators, confirmed by culture methods.
        • Physical Parameters: Measurement of critical process parameters (EO concentration, temperature, relative humidity, time) meeting defined specifications.
        • Chemical Residuals: Measurement of ethylene oxide residuals meeting ANSI/AAMI/ISO 10993-7 requirements.
        • Sterility Testing: For in-use testing, sterility was confirmed by a flush method per USP, indicating no microbial growth.
    7. The sample size for the training set:

      • Not applicable. This device is a physical sterilizer and does not involve AI or machine learning models that require a training set.
    8. How the ground truth for the training set was established:

      • Not applicable, as no training set is used for this type of device validation.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1